Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Neuronetics, Inc. (NASDAQ: STIM) – Neuronetics, Inc., the developer of NeuroStar® Advanced Therapy, announced today that its depression outcomes...
Neuronetics, Inc. (NASDAQ:STIM) — NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), will present...
NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), announced an expanded partnership with GRW Health,...
NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), announced it has reached its two million treatment...
NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), announced today that more than 1.7 million treatments ...
Neuronetics, Inc., a privately held medical device company widely recognized as the market-leader in transcranial magnetic stimulation (TMS),...
Neuronetics, Inc., a privately held medical device company widely recognized as the market-leader in transcranial magnetic stimulation (TMS) therapy, ...
NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), today announced its depression outcomes registry has...
NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS) therapy, is now the only FDA-cleared TMS treatment in...
NeuroStar announced today the launch of the largest depression outcomes registry ever in patients treated with its TMS (transcranial magnetic...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.